NR2C2AP, which was highly expressed in NSCLC, also known as TRA16, could promote cancer cell growth by enhancing the ERβ signaling pathway and was associated with lymph node metastasis and poor OS (Fang et al., 2013). Here, ESR2 is linked to non-small cell lung carcinoma.